PHI-1 gene amplifications, as reported by Deng et al. [36], are observed in cancers such as BLCA, PRAD, and liver hepatocellular carcinoma (LIHC), leading to elevated PHI-1 expression. The gene discussed is PPP1R14B; the disease is prostate adenocarcinoma.